Evidence map›Paper›PMID 23297421›Full record

Trial reportThe Journal of biological chemistry2013

Regulation of GTP-binding protein (Gαs) expression in human myometrial cells: a role for tumor necrosis factor in modulating Gαs promoter acetylation by transcriptional complexes.

Steve J Webster, Sarah L Waite, Victoria J Cookson, Averil Warren, Raheela Khan, Saurabh V Gandhi, G Nicholas Europe-Finner, Neil R Chapman

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Steve J WebsterAcademic Unit of Reproductive and Developmental Medicine, Department of Human Metabolism, University of Sheffield, Level 4, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, United Kingdom.
Sarah L Waite
Victoria J Cookson
Averil Warren
Raheela Khan
Saurabh V Gandhi
G Nicholas Europe-Finner
Neil R Chapman
Jessop Hospital · GBRoyal Derby Hospital · GBUniversity of Sheffield · GBNewcastle University · GBSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

Medical Research Council G0701322
6 · The paper itself

Abstract

The onset of parturition is associated with a number of proinflammatory mediators that are themselves regulated by the nuclear factor κB (NF-κB) family of transcription factors. In this context, we previously reported that the RelA NF-κB subunit represses transcription and mRNA expression of the proquiescent Gαs gene in human myometrial cells following stimulation with the proinflammatory cytokine TNF. In the present study, we initially defined the functional consequence of this on myometrial contractility. Here we show that, contrary to our initial expectations, TNF did not induce myometrial contractility but did inhibit the relaxation produced by the histone deacetylase inhibitor trichostatin A, an effect that in turn was abolished by the NF-κB inhibitor N(4)-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine. This result suggested a role for TNF in regulating Gαs expression via activating NF-κB and modifying histone acetylation associated with the promoter region of the gene. In this context, we show that the -837 to -618 region of the endogenous Gαs promoter is occupied by cAMP-response element-binding protein (CREB), Egr-1, and Sp1 transcription factors and that CREB-binding protein (CBP) transcriptional complexes form within this region where they induce histone acetylation, resulting in increased Gαs expression. TNF, acting via NF-κB, did not change the levels of CREB, Sp1, or Egr-1 binding to the Gαs promoter, but it induced a significant reduction in the level of CBP. This was associated with increased levels of histone deacetylase-1 and surprisingly an increase in H4K8 acetylation. The latter is discussed herein.

Indexed as

AcetylationAdolescentAdultCells, CulturedFemaleGene Expression RegulationGTP-Binding Protein alpha SubunitsHistone Deacetylase 1Histone Deacetylase InhibitorsHistonesHumansHydroxamic AcidsMultiprotein ComplexesMuscle ProteinsMyometriumResponse ElementsGTP-Binding Protein alpha SubunitsHDAC1 protein, humanHistone Deacetylase 1Histone Deacetylase InhibitorsHistonesHydroxamic AcidsMultiprotein ComplexesMuscle ProteinsRELA protein, humanTranscription Factor RelATranscription Factorstrichostatin ATumor Necrosis Factor-alpha

Identifiers

PMID23297421
PMCPMC3585108
OpenAlexW1970971929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.